Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study

Roger J. Laham, Michael Simons, Marilyn C. Pike et al.|Journal of the American College of Cardiology|2000

Cited by 223